Clinical AI on Trial: Shadow Tools and Governance Gaps | Newsday with Yaw Fellin and Matt Troup

July 20, 2026: A new Nature of Medicine study claims general-purpose LLMs outperform specialized clinical AI, but is that the right benchmark to begin with? Bill and Drex are joined by Yaw Fellin, General Manager of UpToDate at Wolters Kluwer, and Matt Troup, Clinical Strategy Principal at Abridge, to break down what those benchmarks actually measure, why shadow AI is already spreading through health systems, and what "clinical grade" really means. Plus: the first-ever look at UpToDate's new drug dosing feature in Expert AI, and why automaticity bias may be the next liability crisis hiding in plain sight.

Key Points:

• 03:18 Nature Study Breakdown

• 10:25 Shadow AI Reality Check

• 18:37 Transparency and Provenance

• 23:40 Human in the Loop Wrap

Keep up to date on the latest in health IT:

https://thisweekhealth.com/news/

X: This Week Health

LinkedIn: This Week Health

Donate: Alex’s Lemonade Stand: Foundation for Childhood Cancer